Sopharma notified that, in relation to a GSM resolution from Feb 23, 2018 and BoD decision taken on Sep 2, it intends to buy back up to 250 000 shares on Sep 3. The maximum repurchase price is set at BGN 5.50, 52% above Sep 2 close while the minimum was set at BGN 1 per share. The price range is in line with 2018 GSM resolution.